Gastroenterology

Latest News

inflammatory bowel disease | Image credit: Panuwat D - stock.adobe.com
Biosimilar and Biologic Use Increasing in Greek Patients With IBD

April 19th 2025

A retrospective study from a single inflammatory bowel disease (IBD) center in Greece reported that from 2018 to 2022, the use of biologics increased by 28% yearly, and the proportion of patients using biosimilars grew from 33% to 67%.

biosimilar business deal | Image credit: Mongkolchon - stock.adobe.com
Latest Biosimilar Deals Signal Growth Across Immunology, Oncology Markets

April 14th 2025

AI biosimilar syringe | Image credit: Phichaphat - stock.adobe.com
Early Success of Adalimumab Biosimilars Featured at AMCP 2025

April 5th 2025

Biosimilars Gastroenterology Roundup: March 2025
Biosimilars Gastroenterology Roundup: March 2025

April 1st 2025

ibd | Image credit: eddows - stock.adobe.com
Patients With IBD Maintain Therapy 2 Years Post Switching to Infliximab Biosimilar

March 23rd 2025

More News

© 2025 MJH Life Sciences

All rights reserved.